BrainsWay Financial Statements From 2010 to 2024
| BRSYF Stock | USD 3.15 0.00 0.00% |
Check BrainsWay financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BrainsWay's main balance sheet or income statement drivers, such as , as well as many indicators such as . BrainsWay financial statements analysis is a perfect complement when working with BrainsWay Valuation or Volatility modules.
BrainsWay |
BrainsWay Company Operating Margin Analysis
BrainsWay's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current BrainsWay Operating Margin | (0.29) % |
Most of BrainsWay's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BrainsWay is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, BrainsWay has an Operating Margin of -0.2876%. This is 99.18% lower than that of the Healthcare sector and 99.27% lower than that of the Medical Devices industry. The operating margin for all United States stocks is 94.78% lower than that of the firm.
BrainsWay Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BrainsWay's current stock value. Our valuation model uses many indicators to compare BrainsWay value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BrainsWay competition to find correlations between indicators driving BrainsWay's intrinsic value. More Info.BrainsWay is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BrainsWay's earnings, one of the primary drivers of an investment's value.About BrainsWay Financial Statements
BrainsWay stakeholders use historical fundamental indicators, such as BrainsWay's revenue or net income, to determine how well the company is positioned to perform in the future. Although BrainsWay investors may analyze each financial statement separately, they are all interrelated. For example, changes in BrainsWay's assets and liabilities are reflected in the revenues and expenses on BrainsWay's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BrainsWay. Please read more on our technical analysis and fundamental analysis pages.
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 118 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in BrainsWay Pink Sheet
When determining whether BrainsWay offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BrainsWay's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainsway Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainsway Stock:Check out the analysis of BrainsWay Correlation against competitors. For more detail on how to invest in BrainsWay Pink Sheet please use our How to Invest in BrainsWay guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.